Adverum Biotechnologies Inc (ADVM)
11.30
+0.15
(+1.35%)
USD |
NASDAQ |
Apr 19, 16:00
11.30
0.00 (0.00%)
After-Hours: 19:00
Adverum Biotechnologies Market Cap: 234.53M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 231.42M |
| April 17, 2024 | 235.57M |
| April 16, 2024 | 240.96M |
| April 15, 2024 | 239.30M |
| April 12, 2024 | 243.46M |
| April 11, 2024 | 248.44M |
| April 10, 2024 | 248.64M |
| April 09, 2024 | 249.27M |
| April 08, 2024 | 261.10M |
| April 05, 2024 | 261.93M |
| April 04, 2024 | 273.34M |
| April 03, 2024 | 277.08M |
| April 02, 2024 | 278.12M |
| April 01, 2024 | 288.29M |
| March 28, 2024 | 293.47M |
| March 27, 2024 | 304.27M |
| March 26, 2024 | 293.68M |
| March 25, 2024 | 310.29M |
| March 22, 2024 | 333.32M |
| March 21, 2024 | 306.13M |
| March 20, 2024 | 315.47M |
| March 19, 2024 | 342.46M |
| March 18, 2024 | 367.36M |
| March 15, 2024 | 352.83M |
| March 14, 2024 | 359.06M |
| Date | Value |
|---|---|
| March 13, 2024 | 373.59M |
| March 12, 2024 | 375.66M |
| March 11, 2024 | 371.51M |
| March 08, 2024 | 390.19M |
| March 07, 2024 | 398.18M |
| March 06, 2024 | 383.66M |
| March 05, 2024 | 389.88M |
| March 04, 2024 | 408.55M |
| March 01, 2024 | 408.55M |
| February 29, 2024 | 410.62M |
| February 28, 2024 | 408.11M |
| February 27, 2024 | 414.33M |
| February 26, 2024 | 403.97M |
| February 23, 2024 | 414.33M |
| February 22, 2024 | 435.04M |
| February 21, 2024 | 408.11M |
| February 20, 2024 | 406.04M |
| February 16, 2024 | 420.54M |
| February 15, 2024 | 414.33M |
| February 14, 2024 | 435.04M |
| February 13, 2024 | 474.40M |
| February 12, 2024 | 412.25M |
| February 09, 2024 | 358.39M |
| February 08, 2024 | 408.11M |
| February 07, 2024 | 582.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
53.85M
Minimum
Dec 27 2022
2.059B
Maximum
Jun 23 2020
496.19M
Average
235.54M
Median
Oct 04 2021
Market Cap Benchmarks
| Karyopharm Therapeutics Inc | 134.05M |
| Ardelyx Inc | 1.512B |
| Minerva Neurosciences Inc | 17.41M |
| Arcutis Biotherapeutics Inc | 1.044B |
| 4D Molecular Therapeutics Inc | 1.257B |
Market Cap Related Metrics
| Price to Book Value | 2.810 |
| Price | 11.30 |
| Earnings Yield | -102.7% |